In the MMR-deficient EC group, 9 (39.1%) patients had positive family history of malignancy, including colorectal cancer (4 cases), gastric cancer (2 cases), breast cancer (2 cases), and endometrial cancer (1 case). Here, MRC1 is linked to breast carcinoma.